2018
DOI: 10.2147/ott.s175808
|View full text |Cite|
|
Sign up to set email alerts
|

<em>SMAGP</em> a novel biomarker of cervical cancer development and progression

Abstract: IntroductionCervical cancer, one of the most common malignant gynecological tumors, is a significant burden on the health of females worldwide. The purpose of this study was to investigate genes associated with lymph node metastasis in cervical cancer.MethodsWe report on the lymph node metastasis-associated gene, small cell adhesion glycoprotein (SMAGP), as a key regulator of cervical cancer development and progression. SMAGP expression levels were investigated in 70 cervical squamous cell carcinoma samples an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Cervical cancer is the second most common cancer in women, and the majority of female cancer deaths occur in developing countries 1. Various treatments based on the tumor grade and stage, including surgery and radiation therapy, are available for cervical cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Cervical cancer is the second most common cancer in women, and the majority of female cancer deaths occur in developing countries 1. Various treatments based on the tumor grade and stage, including surgery and radiation therapy, are available for cervical cancer.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, CCDC167 was reported to be a regulator of cell cycle and served as a potential therapeutic target in breast cancer ( 75 ). Small Cell Adhesion Glycoprotein (SMAGP) was reported as a biomarker of cervical cancer development and progression ( 76 ).…”
Section: Discussionmentioning
confidence: 99%
“…High DVL3 expression is associated with poor prognosis in patients with lung cancer (43,44). SMAGP encodes a transmembrane glycoprotein that plays an important role in tumor invasion and metastasis (45)(46)(47). STRN4 belongs to the striatin family and functions as a co-factor (48), particularly in cancerrelated pathways (49) in prostate (50), lung (51), and gastric (52) cancers.…”
Section: Discussionmentioning
confidence: 99%